Healthcare Startups funded by Y Combinator (YC) 2024

Ginkgo Bioworks is the organism company. We design custom organisms for customers across multiple markets. We build our foundries to scale the process of organism engineering using software and hardware automation. Organism engineers at Ginkgo learn from nature to develop new organisms that replace technology with biology.

Diassess Inc. is revolutionizing the way infectious diseases are prevented, diagnosed, and monitored by developing the tools necessary to empower people to become knowledgeable about their health. We produce inexpensive, disposable health diagnostic hardware that transforms any smartphone into a portable, real-time health-monitoring device for rapid, accessible, multiplexed analysis of bodily fluids anywhere in the world.

We make oral drugs to treat and prevent viral infections - like COVID-19.

Notable Labs is building a personalized drug discovery platform to identify treatment options for relapsed and refractory cancer patients — starting with blood cancer — to address the long tail of cancer treatment. We look at a person’s actual cancer cells, test combinations of FDA approved drugs, and see which combinations kill the cancer cells and leave the healthy cells alive. We focus on combinations because cancer is often difficult to target with just one drug and starting with a single drug can lead to resistant clones or relapse. We're building a highly automated lab in Foster City running on our custom software and are currently testing relapsed/refractory cancer patients as well as samples from a variety of pharma/biotech partnerships. https://www.notablelabs.com/careers

Clipboard Health exists to lift as many people up the socioeconomic ladder as possible. We dramatically improve lives by letting healthcare professionals turn extra time and ambition into career growth and financial opportunity. We achieve this with our app-based marketplace that connects healthcare facilities and healthcare professionals, allowing healthcare professionals to book on-demand shifts and healthcare facilities to access on-demand talent. Our mission is to enable healthcare professionals to work when and where they want and to enable healthcare facilities to meet their talent needs. Clipboard Health is a fast-growing Series C startup with classic two-sided network effects. We have product-market fit, generate substantial revenue, and we are helping nurses fix healthcare one shift at a time. Clipboard Health is a diverse and inclusive company with a global, remote-first team of hundreds of people. We’ve been featured on YC’s Top Companies and grown our revenue 25x in the last 18 months. We need your help to keep growing so we can serve more healthcare professionals, healthcare facilities, and patients.

Malama enables HIPAA-compliant remote monitoring of diabetes in pregnancy, a condition that affects nearly 1 in 5 women. We will lower C-section and preterm birth rates by making it easy for patients and providers to track glucose and meal data. We launched in August 2022 and signed 5 pilot partners including Stanford Hospital and Santa Clara Valley Medical in two weeks, and have a pipeline of 30 more. Mika previously led clinical product innovation at UnitedHealthcare, the largest health insurance company in the world. Orlando, our technical cofounder, was a senior software engineer at AirBnb and Daniela, our creative cofounder, led brand strategy and design for L’Oreal. Malama is backed by the Stanford d.school, Y Combinator (S22), Alpine Investors and more.

Makani Science is a medical device company based in Irvine, California. We have created the world's first wireless patch that can accurately and continuously monitor breathing. The company is co-founded by Dr. Michelle Khine and Dr. Michael Chu, two experts in the wearable monitoring space from the University of California, Irvine. The Makani Science system will collect unique breathing waveforms from patients in everyday environments to create the first large database of respiratory patterns associated with different diseases. Data will be collected through systems sold to our initial beachhead market, where we will help improve monitoring safety in patients being sedated for medical procedures. Our long-term goal is to combine machine learning with this database to identify and predict respiratory complications for different patient populations. We have a highly experienced team and will be FDA cleared in our beachhead market within a year.

We are making a new fertility treatment that infertile couples can order with a click of a button to help them conceive at home. Our technology increases the likelihood of pregnancy by guiding significantly higher number of sperms towards the ovum using a proprietary combination of surface features and microenvironment optimization. The fertility treatments available today, such as in-vitro fertilization (IVF) and intra-uterine insemination (IUI), are psychologically and financially draining and come with considerable treatment-associated risks. Furthermore, over 25 million women of reproductive age in the US have limited nearby access to fertility treatment.

Blueberry Medical provides concierge pediatric care with at-home medical diagnostics and an always-available team of Pediatricians. Blueberry handles twice as may illnesses as any other telemedicine provider and has proven to reduce ER costs by 50%.

Parallel Bio created a human 'immune system in a dish' to discover drugs and immunotherapies more likely to work in patients. Our platform has all of the same elements as a human immune system, meaning you can test drugs and vaccines as if you were testing them in actual patients from the start. The biggest reason why 95% of new drugs fail is that they were tested in mice - but with our human platform, pharma companies will know which drugs will successfully treat patients, speeding up the process and reducing the cost. To date our platform has successfully been used to test 12 drugs, and vaccines against 8 different diseases. The company is founded by Robert DiFazio, a former Stanford R&D director with a PhD in immunology, and Juliana Hilliard, a former System1 Biosciences R&D lead with an MSc in bioengineering, both of whom have led drug discovery programs for years.

We're a SaaS company with emphasis on Service, and we have a mission: to improve the happiness of scientists and the quality of their research. HappiLabs provides a service called the Virtual Lab Manager. We offer PhD level, former scientists to help with safety and regulatory, product research, lab shopping, negotiating, purchasing, inventory, and bookkeeping. Our software tools, such as the ETA Dashboard and the HappiApp, make it easy to request purchases, manage inventory, and check-in packages upon delivery. HappiLabs also has one of the most extensive databases of product prices. These tools, and experienced humans, make us the smartest lab managers in the world. Another way to think of us is an outsourced purchasing department and/or a personal assistant for your scientists. Based in Chicago, and some presence in San Francisco. If you're a newly funded PI, a startup, small biotech, or work with purchasing as a big pharma/biotech, you can use our help.

We are on a mission to help people understand what influence how they feel and what they can do to feel better. Stoic has more than 3 000 000 downloads, 50 000 reviews with a 4.8/5 average and you can find it here http://apple.co/-stoic and here http://apple.co/stoic

Scanbase makes it easy for medical companies to convert photos of rapid diagnostic tests into results. We do this by providing a simple API that any medical company can access.

If we've learned anything in the last few years it's that spending time with our friends and family is essential to our well-being and happiness. Unfortunately, loud and noisy places like weddings and family gatherings hinder human connection, especially for the hearing impaired. In fact, the biggest unmet need in the entire hearing healthcare industry is hearing in noisy places. AudioFocus helps patients hear in these environments by only enhancing voices nearby the patients and ignoring ones farther away. We do this using acoustics informed machine learning and custom microphone array design. Our goal is to increase the adoption rate of 37M US adults with hearing loss, only 8M use hearing aids today. Founded by Auditory Neuroscientist & AI expert and a Hearing Aid hardware design expert.

MICSI is introducing AI software that doubles resolution and halves scan time. This breakthrough enables imaging centers to significantly enhance their capacity and patient throughput, potentially saving countless lives and generating an additional $2 million of revenue per MRI scanner. Our initial offering serves as a stepping stone toward the company’s larger vision of transforming the MRI into a truly quantitative instrument that is capable of providing highly reproducible data for more accurate diagnoses and patient management.

C16 Biosciences is decarbonizing consumer products supply chains by producing next-generation ingredients. The company's biomanufacturing platform produces better performing, more sustainable alternatives to oils and fats, and their first product is an alternative to palm oil. The company owns and operates Palmless™ alternative fats and oils.

At CellChorus, we apply artificial intelligence to evaluate thousands of microscopy videos in parallel to evaluate how immune cells move, interact and perform over time. This allows our customers to discover, develop, manufacture and deliver cell therapies, antibodies, vaccines and other novel therapies faster, at lower expense, and with higher rates of success. Our customers include top-25 biopharma companies and seed-stage biotechs that are developing cell therapies, antibody therapeutics and vaccines (including one of the few companies with an approved CAR T cell therapy). Hear from the team at https://www.youtube.com/watch?v=IE9x_tm0XnI

Revolve is building the world’s only surgical robot designed for every operating room. Its simple yet powerful design makes it the only robot that can service the 1M+ abdominal surgeries performed outside of hospitals in the US every year. Revolve’s surgical robotics platform has been developed in collaboration with over 50 surgeons, resulting in a system that is just 1% of the size and cost of competitor devices.

Dermatologist 👩🏻‍⚕️ virtual clinic in LATAM, with great dermatologists that consult, prescribe and send treatment to your doorstep In 🇲🇽 Mexico 8 out of 10 teenagers have acne, and there is only a ratio of 1 Dermatologist 👨🏽‍⚕️ per 50,000 🌎 population.

We are combining synthetic biology and artificial intelligence to make cancer detection as easy as a pregnancy test. Cleancard is bringing lab-grade diagnostics into the comfort of your home. Our novel method enables robust diagnostics and biomarker tracking from the urine in just 30 minutes. Our rapid at-home screens can identify prostate, bladder and ovarian cancers. We are constantly expanding the number of conditions we can detect from a single sample using our platform technology.

Helium Health provides a suite of technology for healthcare providers, payers and patients across Africa — most prominent of which is our maiden electronic medical records (EMR) & hospital management information system (HMIS) for emerging markets.

Founded in 2010, Lygos is providing biotechnology solutions for today’s renewable chemical challenges. They engineer microbes to convert sugars into high-value, industrial chemicals, targeting compounds where biological production is cost-advantaged over petrochemical production.

Subscription model pharmacy for patients with chronic diseases in Latin America. We delivery medicine every month and help with the insurance reimbursement. We're currently operating in Mexico.

At Tuva Health, we make open source software that cleans and transforms messy healthcare data. We’re founded by Aaron Neiderhiser and Coco Zuloaga, former senior execs from Health Catalyst and Strive Health. We realized data transformation and data quality is the fundamental problem preventing the healthcare industry from building scalable data products. We launched Tuva and joined the W22 batch of Y Combinator to solve this problem for the entire industry. Since January 1st, we signed our first customer (paying $10k per month) and completed the first major release of the Tuva Project. At Tuva, our goal is to (1) become the open standard for healthcare data transformation and (2) build the data network for multi-site benchmarking, research, and machine learning on top of this open standard.

Moons manufactures and sells orthodontic clear aligners in LATAM. Our focus is on providing excellent patient service whilst keeping prices accessible - we can do this because we make the aligners ourselves in our dental laboratory and sell the aligners exclusively in our own clinics

Inflow is a self-help app for people to manage their ADHD. They provide support through psychoeducation, habit development, and community.

At InVision, we use AI to help streamline the interpretation of ultrasounds and identify diseases that may have been missed by human readers. Our models have been tightly integrated into the clinical workflow to allow easy usage by clinicians. Our work has previously been peer-reviewed and published in several top medical venues, including Nature (2020), Nature Medicine (2021), Lancet Digital Health (2021), JAMA Cardiology (2022). Results from our blinded and randomized clinical trial on evaluating cardiac function have also been recently presented as a Late Breaking Clinical Trial at the European Society of Cardiology.

We're a primary care practice that helps residents of senior living communities lead healthier, happy lives. Our mission is to keep senior living residents healthy—by keeping them away from hospitals where exposure to health risks is high. Through our new clinical care delivery model, we bring clinicians right into senior living communities, providing safer, more convenient primary care. Pine Park partners with senior living communities to provide primary care to their residents, building a value-based care model where we keep patients healthier. This allows us to provide comprehensive healthcare on-site, see patients regularly, and better support their holistic health.

Have you ever wondered why it's so hard for physicians to communicate quickly and why the leading cause of preventable death is still a delay in communication? Our team has built the solution for this. Medigram is a team of tier 1 health system CxO IT executives, technologists, SaaS exec, physicians, engineers, and data experts. We have developed a breakthrough service for the medical industry to save lives and for hospitals to make millions per year. Medigram instantly flags insights from clinician chats for immediate insight into hospital operations and patient care. This reduces critical response times by 50%. We've designed this system to provide instant, reliable messaging (including images and audio files) across very complicated network environments in hospitals. Medigram is secure, designed for HIPAA, and a full stack system which includes database back end, middleware, logic, and client apps for iOS, Android, desktop, and the web. Our solution to this is Mobile Intelligence For Healthcare by providing a secure, intelligent workflow management platform for the patient care ecosystem and medical professionals. Within the healthcare environment, you have physicians, the patient care team, EMR, workflow, data, and administration which needs to be tied together with intelligence through Medigram.

H1 helps connect the healthcare ecosystem by providing a global platform of every healthcare professional and healthcare organization.

SaveIN connects people with quality healthcare practices near them and enables them to split their entire medical and wellness bills into monthly instalments. Over 80% of healthcare expense in India is borne out of pocket since less than 10% of Indians have private health insurance. On top of this medical inflation is 15% per annum, thereby making paying for private care expensive and frictional. 5000+ healthcare practices in India now use SaveIN to be discovered by millions of high intent customers near them and offer instant, monthly payment plans for all healthcare services, thereby making it a win-win proposition for all.

Healthtech-1 automates repetitive processes for healthcare systems. We’re starting with the world’s most famous: the NHS. We’re already live in over 400+ primary care practices. Based out of Raj's parents' Primary Care practice the Healthtech 1 team are systematically digitising the repetitive processes they experience everyday, saving thousands of hours of staff time. Why now? The UK's National Health Service (NHS) delivers free healthcare in 590 million patient contacts every year. Post-pandemic, Britain's most treasured institution is in crisis. Patient satisfaction is at 25 year low and 1/7 staff are applying for Non-NHS jobs fuelling an 11% recruitment gap. By digitising the 100s of repetitive processes in healthcare, Healthtech 1 will reverse the trend, and produce the world's most productive health care system.

Kips Health enables physical therapists to automatically collect RTM reimbursements with only 5 minutes of work.

Cofactor uses RNA and Predictive Immune Modeling to build better biomarkers and improve patient outcomes. Led by Jarret Glasscock and a group of expert human genome scientists,Cofactor has built a new category of diagnostic technology powered by unique and powerful RNA data models built on terabytes of data. The team recently had their technology validation peer-reviewed by the organizations that set standards for diagnostic technology (CAP, AMP) and is publishing in the Journal of Molecular Diagnostics. In addition, the team made news when Cancer Physicians who sit on the committee for patient treatment guidelines (NCCN) presented a clinical study using Cofactor’s technology showing superiority in predicting the patients who will respond to immunotherapy. This initial application is an acute problem recognized widely in the rapidly developing immunotherapy industry and represents north of a billion dollar TAM. After a number of recent key milestones, the team is taking the technology more broadly to 50% of cancers diagnosed in the US. Current investors include Menlo Ventures, DCVC, and Ascension Ventures (this last investor representing the funding arm for 13 National U.S. Healthcare Systems).

iollo is an at-home metabolomics test to extend your healthy lifespan. We measure more than 500 biomarkers in blood and use AI to automatically match you with dietary, behavioral, and therapeutic interventions.

Navigating chronic illness is an isolating and lonely process which ultimately reduces medical adherence and adversely impacts outcomes. There are over 100 deadly chronic conditions as 1 out of 2 Americans is currently living with at least 1 chronic condition. The US healthcare system has over $1 trillion dollars in direct costs. Medical adherence rates for therapeutic programs and medicine are only 50% because patients feel lonely, isolated, and unsupported in their chronic illness journey. Reviving Mind is an in-network telehealth provider that improves clinical outcomes and program adherence for the senior medicare and medicare-advantage population that is plagued with loneliness and chronic illness. This is done through a novel and proprietary clinical program and technology platform that integrates virtual, private, curated, and professionally led groups that scale up to 8-patients with individualized and goal oriented lifestyle medicine coaching that is automated but managed by a licensed provider. Scaling rapidly across the United States.

About 50% of all out-of-pocket payments get never collected in U.S. healthcare. Collectly helps medical groups and practices accelerate and increase patient cash flow, decrease costs to collect, and increase patient satisfaction.

Our mission is to improve quality of life for millions of people by providing easy, immediate access to the world’s best sleep care. Sleep Reset is a digital, personalized sleep clinic, available in a convenient mobile app for iOS and Android. Our program was designed in partnership with leading sleep experts from top sleep clinics and universities. The program improves sleep and reduces sleep anxiety with the most effective methods from sleep clinics, including strategies based on Cognitive Behavioral Therapy for Insomnia (CBT-i) which are proven to be more effective than sleeping pills. Throughout our program, each member is paired with a dedicated sleep coach who personalizes their program. It’s a life-long, sustainable solution to sleep better in weeks, with no pills or melatonin needed – which means no grogginess, side effects, or dependency. Sleep Reset has been covered in Forbes, TechCrunch, and INSIDER. The company was founded by Yunha Kim, a serial entrepreneur recognized by Forbes as 30 Under 30 and is backed by top Silicon Valley investors including YCombinator, Foundation Capital, New Enterprise Associates, Stanford University and 20+ founders/executives of leading companies.

In a nutshell: many diseases are caused by how much your cells squeeze (asthma, fibrosis, others). We discover drugs that control how much cells squeeze, with ease, to treat disease. We use patented bioMEMS technology to turn cell strength (cells' ability to pull/ squeeze) into a quantifiable metric in drug discovery, to help find better drugs for mechanical diseases. We screen 100,000s of drugs against numerous contractile human cell types to comprehensively map human mechanobiology (the "contractome") and identify promising drug development starting points to deliver novel medicines to treat mechanically-driven diseases including asthma, hypertension, preterm labor, fibrosis, and others.

Momentu is a corporate mental health platform for Latin America. We address mental health challenges in employees through an emotional test, where we understand their needs and provide support through digital content, therapy and coaching sessions. We are already working with top companies in LATAM such as Fintual, La Haus, Clara, Grupo Ecopetrol, Axa Colpatria. We served thousands of employees in LATAM in over 11 countries.

We are solving clinician staffing shortages for hospitals by automating routine patient-facing tasks.

We help large provider groups and hospitals take their most mundane repetitive tasks and turn them into automated workflows. Freeing up healthcare workers to focus on the important stuff, like patients

Cancer is a genetic disease. We know this from decades of human and veterinary cancer research. Precision medicine and targeted therapies are successfully used to treat humans with cancer. At FidoCure®, we bring this approach to the world of veterinary medicine. FidoCure® empowers veterinarians to offer genetic sequencing and targeted therapies to treat dogs with cancer. We are committed to expanding the veterinary oncology toolbox for both diagnostics and therapeutics. Our veterinary partners have treated thousands of dogs over the past 30 years and work closely with the growing FidoCure® network of over 143 clinics and 180 forward-thinking veterinary oncologists throughout the US. Together, we can combat canine cancer!

Sanvivo builds a multisided platform to enable customers to order medications, get pharmaceutical advice, and book health services at local pharmacies in Europe. Just like Shopify for pharmacies. Sanvivo gives pharmacies software to take, fill and schedule delivery for online orders. We also bring instant demand through integrations with 3rd party consumer delivery companies. Almost all pharmacies in Europe are, by law, local 1-person businesses. And they are not ready for online orders. Regulatory changes require pharmacies to take and fill e-prescriptions (roll-out Jan-23), but many have no way to do this online today. Sanvivo uses technology to give local pharmacies digital superpowers, enabling them to combine fast supply and high-quality consultation with state of the are e-commerce solutions.

ReleviumBio is developing an injectable gel for knee osteoarthritis. Approximately half the population will be diagnosed with this pain and progressive disease. Right now, patients have to undergo not only repeat injections to control their pain, but also have to take strong oral medications. Because the disease is progressive and only gets worse over time, many patients end up on highly addictive, high-dose opioids. To date, we have secured $3.7 million in non dilutive funding and completed preclinical testing. We demonstrated that our drug is safe, selectively blocks nerves that transmit pain, and provides pain relief that lasts four times as long. My co-founder and I are Chemists with PhDs in Biomedical Engineering and we have an experienced leadership team already in place. Insurance currently pays $770 per six-monthly treatment for knee osteoarthritis. With 5 million patients in the US, this represents a $7.7 Bn market opportunity. This platform biotherapeutic can also be used to treat other joints affects by osteoarthritis such as the hip and ankle, where the same problems exist in treatment care.

Metriport helps healthcare organizations access and manage comprehensive patient medical data. Through a single integration, Metriport ensures clinical accuracy and completeness of medical information to providers, delivering comprehensive consolidated patient clinical data at the point-of-care. By standardizing, de-duplicating, consolidating, and hydrating the data with medical code crosswalking, providers get a rich understanding of their patients' medical histories through Metriport. Metriport is the only open-source solution of its kind that offers all these integrations in a single platform, and standardizes complex data formats into industry standards such as FHIR and C-CDA. As a developer-first, HIPAA and SOC 2 Type II compliant interoperability solution, Metriport is powering the next wave of innovators in healthcare, creating an internet for healthcare data.

Liv Labs is a consumer healthtech company making modern solutions for incontinence. 29 million American women worry about leaking pee in public: an $8B market. Liv Labs is developing convenient self-care versions of proven-effective clinical treatments, including adaptive health coaching software and a novel continence pessary. Device inventor, Carly Price, reimagined the humble pillow for Casper and now leads digital retail design at Walmart. Company CEO, Melody Roberts, incubated digital service experiences now scaling globally at McDonald’s and Panera. We’ve raised $2.6M, including NIH and NSF grants, based on stellar effectiveness data and user feedback like, “With this, surgery is off the table.” US, European and Hong Kong utility patents have issued; Australia will soon. Our FDA-reviewed clinical trial launched at Northwestern University and continues at the OSU and UAB.

Current Description: RTHM provides virtual-first care for complex illness including Long COVID, ME/CFS, POTS, and mast cell activation. Many clinics focus on teaching patients how to better cope with symptoms, which is helpful, but we don’t stop there. We develop collaborations & partnerships so our patients access to the most promising testing and root-cause directed early therapies for their illness(es) with the goal of simplifying and streamlining the most efficient and effective clinical pathways so they can be scaled in the form of low cost online modules overseen remotely by clinicians. In conjunction with clinical care, RTHM operates a clinical lab and collects deep molecular data with robust clinical context to develop AI-powered diagnostics and better ways of predicting which treatments may work best for whom.

SmartSpot is a post Series-A stealth startup backed by Founders Fund and Khosla Ventures that uses computer vision to deliver an unparalleled fitness training experience to your home. Our unique hardware solution gives amazing trainers the ability to see their class participants in real time and deliver detailed advice that was previously only possible in person.

We are Pulse Active Stations Network and are setting up a network of connected IOT-enabled “Make in India” Smart Health Machines known as the Pulse Active Stations Network. We have conducted over 600,000 Health Check-ups and through our Pulse Active Station Smart Health Machines, we conduct mass screening for NCD risk factors such as Obesity, Hypertension and other factors to empower people to take informed decisions for theirs and their family's health.

At Diffuse Bio we’re building a push-button entirely AI software platform for molecular design, leveraging breakthroughs in generative AI. Our team has been behind breakthroughs in AI protein design for the past 6 years, including the first experimental validation of AI-generated proteins and diffusion models for protein structure and sequence.

We are developing an implantable therapeutic tissue that will be surgically delivered to patients suffering from end stage renal disease. Upon implantation, this tissue will supplement the patient's renal function, eliminating their dependency on dialysis and improving their disease status. This has the potential to not only get these patients off dialysis - a significant impact for them and their families - but to greatly extend the time required before kidney transplantation is essential.

We are developing utility-scale molecular sensing using gamified citizen science and a unique, toy-like R&D device.

Sonia is an AI therapist that conducts entire therapy sessions both by voice and text via a phone app. 70 million Americans who struggle with their mental health can now access therapy for $200 per year instead of $200 per session. Founded by a team of MIT researchers who published 9 papers on AI at conferences like NeurIPS.

Cell and gene therapy promises to one day cure any disease; Modulari-T’s Platform produces the tools to fulfill that promise. Modulari-T has designed a new family of synthetic genes that can reprogram cells to better sense their environment and modify their behavior accordingly. This can be used to engineer immune cells to efficiently recognize and kill cancer cells or to create stem cells able to regenerate any tissue. Modulari-T looks to expand its technology to reach every area of cell therapy and become the platform of reference for cell engineering.

Using infrared technology, we provide a non-invasive, painless, private, and accurate adjunct breast cancer screening in under 10 minutes. Our Eva Centers are located in shopping centers.

Out-of-pocket healthcare costs are skyrocketing and every day, people all across America are forced to make difficult decisions about their health. Lively is the benefits solutions provider that gets it right. We designed our solutions to take the guesswork out of managing benefits. And our innovative features are built to simplify benefits administration and evolve with your business. Managing wellness and wealth takes more than a series of transactions. By combining robust features with unparalleled service, we make benefits administration effortless, even when time and energy are limited. Experience benefits administration as it should be with Lively. Go to www.livelyme.com to learn about how HSAs other modern employee benefits can help you and your team.

Qvin is the first and only healthcare service to scientifically prove menstrual blood can test for critical health information – just like a traditional laboratory blood test. Women's health has always been under-prioritized in science. We still operate in a world built by men, for men. It’s why in 2014, Dr. Sara Naseri and Søren Therkelsen started Qvin to research, develop, and patent a product that powers an underserved and understudied population—women. Over 70% of the decisions our doctors make are influenced by blood test results. Every month, 1.8 billion people across the world menstruate. However, the blood our bodies naturally deliver every month has never been explored as a testing source. And yet, menstrual blood has been left unexplored. Qvin is the first and only healthcare service to use period blood as a non-invasive blood test. We exist to give women an easy, insightful way to monitor existing health issues, proactively screen for others, and go into doctor visits more informed and confident of their own health. Our health technology platform helps women manage their health better through a non-invasive blood collection device named the Q-Pad™. All of us at Qvin want to move the study of women forward. We want to close the gender data gap. And we stand for every person who identifies with women, however they define it.

Manage data & analyses with an open-source Python framework. Collaborate across dry and wetlab in a distributed data hub. Get started on your laptop and deploy anywhere.

REPROSENT is a patient-driven care system that harnesses patients' time to relieve overburdened medical teams. With an app that elevates the role of both patients and their loved ones, REPROSENT helps patients stay on track, capture previously untapped data about their lived experience, and receive timely triage that improves their health outcomes. By making crucial patient information actionable, REPROSENT enables doctors to focus their time on personalized treatment, transforming the way medical care is provided.

At XGenomes, we are building a technology comprising novel biochemistry, hardware and algorithms for sequencing DNA. Our product will be streamlined: there is zero library preparation; we sequence directly on unadulterated single molecules of DNA; DNA extraction will be integrated with sequencing; there is no bioinformatics bottleneck. The sequence we produce will be of unprecedented accuracy due to several layers of in-built redundancy including the sequencing both strands of the double-helix concurrently. The sequence we produce will be complete, encompassing: structural as well as single nucleotide variants; long-range haplotype phase; the repetitive "dark matter" of the genome. The cost of goods (consumables) of sequencing will be <$10, which will allow us to price our product at a level that will help grow the market while still achieving >90% margin. We will start by offering access as a service to high value customers, which be followed by a razor and blade model of selling instruments and consumables.

At Pirouette, we have developed a low-profile, disk-shaped, rugged injection device with a patient-centric focus on affordability, portability, and usability. The patented device, based on extensive patient input, is designed to make administering an injection as easy as pushing a button. This allows individuals with limited or no training to easily and intuitively perform an injection on themselves or others.

We help healthcare companies run their practices. Eligibility, BI, claims, patient payments? Shoot us an email at founders@aperohealth.com Apero is a Y-Combinator-backed startup based in San Francisco bringing transparency and ease to medical billing. As one of the top startups from the Summer 2019 Y Combinator batch, we have raised from well-known investors including the creator of Gmail Paul Buchheit and the founders of Doctor on Demand, Gusto and Reddit, and serve startups that have raised over $1B in Venture Capital. The founding team are Stanford CS and Berkeley grads and include the CTO of Doctor on Demand having helped raised $240m and process millions of video calls. We are also hiring for engineers and product-minded operations people interested in giving price transparency to patients and providers. We serve practices nationwide, and integrate with leading EHRs as well.

Developing the next generation of psychedelic therapeutics for mental health indications. We design novel altered states of consciousness using machine learning, human experiential data, and molecular pharmacology.

Selia Connects individuals and certified psychologists and psychiatrists with an online platform for one-on-one therapy delivered via video call. Selia offers convenient and affordable access to a fully-credentialed network of highly qualified providers while giving individuals self-guided tools, journaling and mood tracking to help them achieve their goals. We created Selia to address the unmet and growing demand for mental health services for Spanish speaking Latam everywhere. Our business-to-consumer (“B2C”) channel, made of individual consumers who pay directly to our platform, and our business-to-business (“B2B”) channel, that consist from start ups to enterprise clients such as Experian, Starbucks, Habi and more

Curebase is reinventing decentralized clinical trials to help the vast majority of potential patients that currently cannot access clinical research. Curebase’s vision is that any patient, no matter where they are located, should be able to participate in clinical trials at home and with their own doctors. This is made possible through a unique suite of tools, including all-in-one eClinical software and virtual research sites, designed to engage patients in clinical trials across all settings, be it at home, at their local clinic, or other places in their community.

Legion Health is a pioneering telepsychiatry company dedicated to transforming patient care through advanced technology. We leverage cutting-edge language models and robust data analytics to enhance our patient-provider interactions, improve access to mental health services, and streamline our clinical operations. Our mission is to integrate innovative AI solutions into every facet of psychiatric care, ensuring providers and patients benefit from the most effective and efficient treatment strategies.

Memora Health helps healthcare organizations digitize and automate complex care workflows, making them simple for patients and clinicians to navigate. Memora ingests existing data on clinical workflows, converts them into cohesive messaging journeys that guide patients through their care episodes, and automates the completion of simple follow-up tasks in the EMR. Memora's platform reduces care team notifications by nearly 40%, has a >70 average NPS, and has improved clinical outcomes across various populations. Contact us at info@memorahealth.com

Eligible is the nation's first insurance billing platform built for builders. Founded in Mountain View California in 2011, Eligible's platform gives bootstrapping healthcare startups the scale of enterprise, and the Fortune 500s the agility of the hungry entrepreneur. Eligible has been listed as one of Business Insider’s 19 Hottest Startups to Watch and Katelyn has been featured in Forbes 30 Under 30 in Healthcare, Fast Company's Most Creative People in Business, and was named a Rising Star of Healthcare by Becker’s IT & CIO Review.

Dear Brightly offers prescription skin products online. Our mission is to get people access to the most effective, dermatologist vetted skincare products for healthy skin, using technology.

X-ZELL™ is a global start-up specialising in rare cell detection technology. Backed by Y Combinator and various high-profile angel investors from around the globe – among them Gmail creator Paul Buchheit – X-ZELL™ has developed a world-first platform technology capable of isolating and visualizing rare and abnormal cells such as Circulating Endothelial Cells (CEC). X-ZELL™’s platform technology is based on four core modules covering the entire spectrum from blood processing through to cell analysis and reporting – with every step performed in-house using patented and proprietary technology. By combining the wisdom of 4,000 years of pathologic research with X-ZELL™’s own, cutting-edge technology, X-ZELL™ ensures robust results and maximum clinical utility across a broad range of medical applications – from research through to medication management, companions diagnostics, relapse control and diagnostic decision-making. More information on www.x-zell.com and @XZELLInc

Akido is a care delivery platform focused on overcoming the complex needs of our most vulnerable populations. We are on a mission to leverage modern technology and proprietary datasets that have historically been locked up in our public health ecosystems in order to radically improve the quality of life and affordability of care for underserved people. We are a fast-growing, impact-focused, Y Combinator company being used nationwide to combat the Covid-19 pandemic, homelessness, and other public health crises. Across the country, health systems and government service providers use Akido to launch new technology-powered public health initiatives that improve the health and well-being of the communities they serve.

We are building a platform of bacterial molecules to awaken our body’s innate ability to control inflammation and heal. Our first indication is Crohn’s Disease, which affects over 500,000 Americans at an annual cost of $10B. After Crohn's disease, we are going for type 1 Diabetes and Multiple Sclerosis.

Delivery of TERT mRNA extends telomeres sufficiently in a few days to reverse over a decade of telomere shortening during normal aging. We are advancing TERT mRNA-based therapies to the clinic.

TrueClaim processes all payments between healthcare providers and companies that self-fund their insurance. Unlike incumbents, TrueClaim uses newly available data and AI to save companies 7% of their healthcare costs.

Astek Diagnostics is building a platform (Eugris) that guides physicians in prescribing appropriate antibiotics for patients with bacterial sepsis in one hour. It is done by detecting the oxygen consumption of the bacteria

We are building high-precision implantable neuromodulation devices that can sense and stimulate neural activity in the brain with the goal of transforming the efficacy and adoption of deep brain stimulation (DBS), an existing FDA-approved therapy used to treat Parkinson’s, essential tremor and epilepsy.

Oncobox believes that many late-stage cancer patients are dying prematurely because doctors lack a data-driven tool to help them decide which drugs currently on the market would most effectively fight individual patients’ specific cancers. That’s where Oncobox comes in. Oncobox is low-cost personalized genetic profiling to help doctors decide which drug to use. In a recent study conducted by leading cancer researchers in Europe and Asia on 900 patients with various late-stage cancers, Oncobox increased the effectiveness of targeted therapies from 25% to 64%. How does Oncobox work? Over 150 targeted cancer drugs are currently on the market. But deciding which of these drugs to give to late-stage cancer patients is not a simple task. Cancer doctors are in a race against the clock. They don’t always know which medication will be most effective for their patients. Because these drugs are expensive and typically have significant side effects, they can’t just try them all. Because of these barriers, targeted cancer therapies are effective only 25% of the time, and 70% of patients with late-stage cancers die due to the toxic side effects of ineffective drugs. Oncobox Dx analyses tumor DNA, RNA, and molecular pathways using algorithms to distinguish which molecular targets are the most crucial for individual cases. Doctors receive a clinically actionable report that shows them which drugs are likely to be most effective on the patient. We actively seek partners from pharma, hospitals/clinicians, payers, and genomic centers. Feel free to contact us at hello@oncobox.com. Our team and the scientific advisory board consisting of leading scientists and researchers from UCLA, Stanford, Johns Hopkins University, Boston University, Tufts University, and Rutgers University.

PostEra is building a modern 21st century biopharma. We're using our advances in machine learning to accelerate Medicinal Chemistry and bring more cures to patients. PostEra advances small molecule programs through partnerships with biopharma while also advancing its own internal pipeline. We've raised $26M from top investors and closed $1Bn in AI partnerships, signing multi-year agreements with Amgen, Pfizer and the NIH. PostEra also launched and led the world's largest open-science drug discovery effort; COVID Moonshot.

We enable people to live their best lives. As we succeed, there is more convenience, healthier communities and thriving businesses. We get medications to those who need them and improve information, access and management of their care and enable businesses to move online and gain access to consumers who need their services

We build software to manage, analyze, and optimize bioprocessing data. Our initial customers are bio-industrial companies, who produce various products in bioreactors.

BillionToOne has developed a DNA molecular counter that increases the cell-free DNA diagnostics resolution by over 1,000 fold, which unlocks transformative improvements in prenatal screening and liquid biopsy for cancers. Unity Screen, BillionToOne's commercially available non-invasive prenatal test (NIPT), is the only NIPT that can assess fetal risk for both recessive conditions and aneuploidies from maternal blood. UNITY Screen continues to grow exponentially and is on its path to becoming the next standard-of-care, with an increasing number of publications showing its accuracy and advantages over other screening methods. We have also recently used our molecular counting technology to develop liquid biopsy tests, which have the potential to completely transform oncology care.

SimplyInsured was founded with one mission: to eliminate fear from health insurance. By changing the way small business owners purchase health insurance with our 100% online platform, we’re transforming a $20 billion dollar industry and delighting thousands of customers. Our unique values-based culture (and extremely talented team) is our core competitive advantage, and each person on our team makes a direct, immediate impact on our business. We value transparency, feedback, bias to action, growth, and an obligation to dissent. Every opinion is respected, we hold each other to extremely high standards, we’re driven by the diversity in our backgrounds, and unified by 100% alignment on our mission. What’s best for the customer is the heart of everything we do, and our customer stories prove it: by changing health insurance we’re literally saving lives. Based in San Francisco, SimplyInsured was founded in 2012 and is back by Bessemer Venture Partners, Polaris Ventures, and Y-Combinator. If you’re up for the challenge of improving health insurance for millions of Americans, we’re just getting started, and we’re growing!

Shiok Meats is a cell-based clean meat company, exclusively working on seafood. Shiok Meats is the first cell-based meat company in Singapore and SE Asia and we employ cellular agriculture to grow seafood meat in the laboratory using cells instead of animals. Shiok in Singapore English slang means fantastic and enjoyable. Our meats are animal-, health- and environment-friendly with the same taste, texture and nutrients, but no cruelty. Our mission is to bring delicious and healthy meat by harvesting from cells instead of animals.

We are developing a new paradigm for consumer health tech wearables by replacing a 100lb optical instrument with an area of silicon smaller than a postage stamp.

Instalab is an at-home blood testing service for 60+ biomarkers that teaches you how to optimize your health, so you can focus on the demands of your career and life without sacrificing long-term health.

We make devices that help cancer patients prevent the side effects of cancer treatment, including hair loss, neuropathy and infertility. Our first product, Lily, is a wearable cap that enables chemotherapy patients to prevent hair loss in a comfortable, portable way, while our second product, Lilac, is the world's first device to prevent the peripheral nerve damage caused by cancer treatment.

At Curvenote we are building the communication and publishing tools for scientists and engineers. In the future, every scientific report will feature interactive graphs with live data that will make it significantly easier to share and reproduce the work.

BrainHi is an automated receptionist for local businesses. Local businesses are in search of new clients and revenue, yet 25% of phone calls to local businesses are missed and 80% of potential clients don’t leave voicemails. BrainHi uses AI to create an automated receptionist that answers missed calls 24/7 and chats with clients to schedule appointments and answer admin questions, resulting in more business. Cofounders Emmanuel and Israel started BrainHi after Hurricane Maria made communicating with doctors offices nearly impossible on the island of Puerto Rico.

Andson Biotech helps pharmaceutical companies measure difficult to detect chemicals that they need to measure while developing and manufacturing drugs like cell-therapies or biologics. Drug companies want to use our technologies to get fast and accurate chemical measurements they do thousands of times per day for drug development and quality control.

Get instant diagnosis for the vast majority of neurological conditions using our Foundational AI.

Snazzy is a direct-to-consumer teledentistry platform for teeth straightening. Our goal is to democratize access to affordable and accessible clear aligner treatment. We leverage teledentistry and offer the highest quality aligners at a fraction of what others charge.